Advertisement
Screener

Hinge Health, Inc. (HNGE) Overview

Hinge Health, Inc. (HNGE) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual 0.52; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual 0.41; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual -0.02; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual -13.10; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$29.61$39.27$52.09$69.08$91.62$121.512025-11-062026-11-06$29.61$39.27$52.09$69.08$91.62$121.512025-05-222026-11-06$29.61$39.27$52.09$69.08$91.62$121.512025-05-222026-11-06$29.61$39.27$52.09$69.08$91.62$121.512025-05-222026-11-06$29.61$39.27$52.09$69.08$91.62$121.512025-05-222026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$115.72
Previous close
$95.21
Change
$20.51
Change (%)
21.54%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

HNGE
+104.97%
S&P 500
(m)

1 year

HNGE
+90.84%
S&P 500
(m)

3 years

HNGE
(m)
S&P 500
(m)

5 years

HNGE
(m)
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual 0.52

-13.18-9.51-5.84-2.181.4931 Mar 2025: estimate (m); actual 1.3131 Mar 2025(m)30 Jun 2025: estimate (m); actual -13.1030 Jun 2025(m)30 Sept 2025: estimate (m); actual -0.0230 Sept 2025(m)31 Mar 2026: estimate (m); actual 0.4131 Mar 2026(m)30 Jun 2026: estimate (m); actual 0.5230 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)0.52(m)(m)
1 Jan 202631 Mar 2026(m)0.41(m)(m)
1 Jul 202530 Sept 2025(m)-0.02(m)(m)
1 Apr 202530 Jun 2025(m)-13.10(m)(m)
1 Jan 202531 Mar 2025(m)1.31(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual -7.77

-8.39-6.47-4.54-2.62-0.7031 Dec 2023: estimate (m); actual -8.3131 Dec 2023(m)31 Dec 2024: estimate (m); actual -0.8831 Dec 2024(m)31 Dec 2025: estimate (m); actual -7.7731 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)-7.77(m)(m)
1 Jan 202431 Dec 2024(m)-0.88(m)(m)
1 Jan 202331 Dec 2023(m)-8.31(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 212.82M ■ Earnings 43.69M — Profit margin 20.53%

-27.60M-2.2%61.12M5.7%149.85M13.6%238.58M21.5%30 Sept 2025: revenue 154.21M; earnings -1.84M; profit margin -1.20%30 Sept 202531 Dec 2025: revenue 170.73M*; earnings 32.09M*; profit margin 18.80%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2025-10-01 to 2025-12-31; USD.31 Dec 202531 Mar 2026: revenue 182.31M; earnings 35.13M; profit margin 19.27%31 Mar 202630 Jun 2026: revenue 212.82M; earnings 43.69M; profit margin 20.53%30 Jun 2026

31 Dec 2025 ■ Revenue 587.86M ■ Earnings -528.26M — Profit margin -89.86%

-662.20M-90.9%-200.87M-61.3%260.46M-31.7%721.79M-2.1%31 Dec 2023: revenue 292.73M; earnings -108.14M; profit margin -36.94%31 Dec 202331 Dec 2024: revenue 390.40M; earnings -11.93M; profit margin -3.06%31 Dec 202431 Dec 2025: revenue 587.86M; earnings -528.26M; profit margin -89.86%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$115.72(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$115.72High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning HNGE

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$109.07M
Profit margin
15.15%
Return on assets · 12 month
14.34%
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
1.88M
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
1.13%*
Total return · month
9.00%*
Total return · quarter
16.85%*
Total return · half year
162.65%*
Total return · year to date
104.97%*
Total return · 1 year
90.84%*
Total return · 3 years
(m)
Total return · 5 years
(m)
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$720.06M
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

Hinge Health, Inc. Overview

View more →

(m)

(m)

SEC CIK
1673743
Industry (SIC)
7374 Services-Computer Processing & Data Preparation
Country of operation
United States
Business address
455 MARKET STREET, 7TH FLOOR, SAN FRANCISCO, California, 94105, United States
Fiscal year end
1231
Phone
415-689-8429